News
Our writer can see the appeal of this recently popular dividend stock from the FTSE 100 index. But will he buy it for his own ...
Scientists at EPFL and AstraZeneca have developed a method to map the atomic-level structure of amorphous drugs, demonstrated ...
The two-year partnership aligns with the company’s mission to transform healthcare and improve patient outcomes through ...
9hon MSN
Best Pharma Stocks to Invest in Now. In this article, we are going to take a look at where AstraZeneca PLC (NASDAQ:AZN) ...
Analysts are still crunching the numbers on the impact of President Donald Trump's executive order from Monday on drug pricing. HSBC analyst Rajesh Kumar says a 20% price cut in government channels ...
A new treatment approach significantly improves survival rates for patients with aggressive, inherited breast cancers, according to researchers. In a trial where cancers were treated with chemotherapy ...
Explore more
We’re winding down earnings season, and the old Wall Street adage that “earnings drive stock prices” continues to prove true.
14h
The Business & Financial Times on MSNTrust Specialist Hospital, AstraZeneca push asthma breakthrough with symbicort accessBy Sandra Agyeiwaa OTOOTrust Specialists Hospital, in partnership with AstraZeneca, has marked World Asthma Day 2025 with a ...
A federal appellate court has handed down the first appellate-level decision addressing the merits of drug manufacturers’ ...
AstraZeneca's Breztri Aerosphere in India is made using a new type of gas (called a next-generation propellant) that does not ...
Phase 1 dataset and late-stage development strategy expected in the third quarter of 2025Eti-cel (UCART20x22) Phase 1 study in relapsed or refractory B-cell non-Hodgkin lymphoma (r/r ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results